Many of our clients suffer from mesothelioma, a fatal cancer of the linings around certain organs, usually the lungs, caused by exposure to asbestos, usually, decades before the disease emerges. Here is one of our previous posts in which we explain some of the basic characteristics of mesothelioma.
People with mesothelioma are normally very sick and by the time the diagnosis is made, they normally have few treatment options and short life expectancies. Because of this serious condition, hopeful new research findings are always welcome.
Important Research Findings
Sbarro Health Research Organization has announced promising findings based on new research headed by Dr. Antonio Giordano with teams at both Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine and the University of Siena in Italy. This research suggests that a drug used to treat pinworm parasites in the human intestine may also impair mesothelioma cells.
This anthelmintic (anti-parasite) drug pyrvinium pamoate (sometimes called PP) was found in the study to “effectively impair both mesothelioma cell growth and migration.” Dr. Giordano stated that repurposing a medication already approved for other uses for use against another disease is faster and cheaper than developing a new drug for the same purpose. Specifically, in these findings, he said that PP weakened the “aggressiveness” of mesothelioma cells.
Seek Medical Advice
Any mesothelioma patient with questions about this research should ask their treating cancer doctors. While many people with mesothelioma participate in clinical research trials, treatment advice is different in every case. Seek specialized, informed medical treatment and advice if you or a loved one has a mesothelioma diagnosis so that you can understand the range of potential treatment options and can determine the next steps with your physicians.